Novartis ' CANTOS Heart Trial Results Could Lead To Drastic Drop In Arthritis Drug Price

But who would have thought at the results of a heart disease study could potentially provide an unexpected financial benefit to those patients with juvenile arthritis.
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NYSE:NVS NASDAQ:AMGN NASDAQ:REGN Source Type: news